Proteome Analysis Reveals Phosphorylation of ATP Synthase Beta -subunit in Human Skeletal Muscle and Proteins with Potential Roles in Type 2 Diabetes
Overview
Authors
Affiliations
Insulin resistance in skeletal muscle is a hallmark feature of type 2 diabetes. An increasing number of enzymes and metabolic pathways have been implicated in the development of insulin resistance. However, the primary cellular cause of insulin resistance remains uncertain. Proteome analysis can quantitate a large number of proteins and their post-translational modifications simultaneously and is a powerful tool to study polygenic diseases like type 2 diabetes. Using this approach on human skeletal muscle biopsies, we have identified eight potential protein markers for type 2 diabetes in the fasting state. The observed changes in protein expression indicate increased cellular stress, e.g. up-regulation of two heat shock proteins, and perturbations in ATP (re)synthesis and mitochondrial metabolism, e.g. down-regulation of ATP synthase beta-subunit and creatine kinase B, in skeletal muscle of patients with type 2 diabetes. Phosphorylation appears to play a key, potentially coordinating role for most of the proteins identified in this study. In particular, we demonstrated that the catalytic beta-subunit of ATP synthase is phosphorylated in vivo and that the levels of a down-regulated ATP synthase beta-subunit phosphoisoform in diabetic muscle correlated inversely with fasting plasma glucose levels. These data suggest a role for phosphorylation of ATP synthase beta-subunit in the regulation of ATP synthesis and that alterations in the regulation of ATP synthesis and cellular stress proteins may contribute to the pathogenesis of type 2 diabetes.
Schulte M, Hochmuth K, Steadham E, Lonergan S, Hansen S, Huff-Lonergan E J Anim Sci. 2024; 102.
PMID: 39279203 PMC: 11491740. DOI: 10.1093/jas/skae272.
mtDNA Single-Nucleotide Variants Associated with Type 2 Diabetes.
Garcia-Gaona E, Garcia-Gregorio A, Garcia-Jimenez C, Lopez-Olaiz M, Mendoza-Ramirez P, Fernandez-Guzman D Curr Issues Mol Biol. 2023; 45(11):8716-8732.
PMID: 37998725 PMC: 10670651. DOI: 10.3390/cimb45110548.
Mitochondrial heterogeneity in diseases.
Chen L, Zhou M, Li H, Liu D, Liao P, Zong Y Signal Transduct Target Ther. 2023; 8(1):311.
PMID: 37607925 PMC: 10444818. DOI: 10.1038/s41392-023-01546-w.
Bettahi I, Krishnankutty R, Jaganjac M, Suleiman N, Ramanjaneya M, Jerobin J Front Endocrinol (Lausanne). 2023; 13:1024832.
PMID: 36876056 PMC: 9982120. DOI: 10.3389/fendo.2022.1024832.
Diabetic sarcopenia: metabolic and molecular appraisal.
Giha H, Alamin O, Sater M Acta Diabetol. 2022; 59(8):989-1000.
PMID: 35429264 DOI: 10.1007/s00592-022-01883-2.